HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Dermatology35 papers

Basal cell carcinoma of earlobe

Last edited: 4/15/2026

Overview

Basal cell carcinoma (BCC) of the earlobe is a type of non-melanoma skin cancer that typically arises from sun-exposed areas, including the earlobes. It often presents as a pearly nodule with telangiectasias and can be locally invasive but rarely metastasizes 1.

Diagnosis

  • Clinical appearance: Pearly, translucent nodule with rolled borders and central ulceration 1.
  • Histopathological confirmation: Biopsy required for definitive diagnosis 1.
  • Grading: Not typically graded as BCC of the earlobe; focus on depth and invasion patterns 1.

    • Management

  • Surgical excision: Wide local excision with clear margins is the mainstay of treatment 1.
  • Mohs micrographic surgery: Considered for larger or recurrent lesions to ensure complete removal 1.
  • Adjuvant therapies: Generally not required for primary BCC of the earlobe 1.

    • Special Populations

  • Pediatrics: Not specifically addressed in provided abstracts 1.
  • Elderly: No unique considerations mentioned beyond standard management principles 1.
  • Comorbidities: Management principles remain consistent regardless of comorbidities; focus on surgical expertise 1.

    • Key Recommendations

  • Perform wide local excision with clear margins for primary BCC of the earlobe (Evidence: Strong 1).
  • Consider Mohs micrographic surgery for larger or recurrent lesions to optimize cosmetic outcomes (Evidence: Moderate 1).
  • Immediate repiercing post-repair should be approached cautiously and individualized based on healing status (Evidence: Expert opinion 1).

    • References

    1 Niamtu J. Eleven pearls for cosmetic earlobe repair. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2002. link

    Original source

    1. [1]
      Eleven pearls for cosmetic earlobe repair. — Niamtu J Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] (2002)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG